Abstract
ABSTRACTWith the widespread use of high-throughput sequencing technologies, understanding biology and cancer heterogeneity has been revolutionized. Recently, several machine-learning models based on transcriptional data have been developed to accurately predict patient’s outcome and clinical response. However, an open-source R package covering state-of-the-art machine learning algorithms for user-friendly access has yet to be developed. Thus, we proposed a flexible computational framework to construct machine learning-based integration model with elegant performance (Mime). Mime streamlined the process of developing predictive models with high accuracy, leveraging complex datasets to identify critical genes associated with prognosis. An in silico combined model based on de novo PIEZO1-associated signatures constructed by Mime demonstrated high accuracy in predicting outcomes of patients compared with other published models. In addition, PIEZO1-associated signatures could also precisely infer immunotherapy response by applying different algorithms in Mime. Finally, SDC1 selected from PIEZO1-associated signatures presented high-potential role in glioma with targeted prospect. Taken together, our package provides a user-friendly solution for constructing machine learning-based integration models and will be greatly expanded to provide valuable insights into current fields.
Publisher
Cold Spring Harbor Laboratory